Persistent Corneal Epithelial Defect: Clinical Trials

1 trial for Persistent Corneal Epithelial Defect, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Persistent Corneal Epithelial Defect: new trials by email Literature Review of Persistent Corneal Epithelial Defect trials Research Report on Persistent Corneal Epithelial Defect

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED
Cenegermin, Vehicle - Persistent Corneal Epithelial Defect
Phase 3RecruitingDompé Farmaceutici S.p.A1502026-06-022026-10-07

Narrower conditions

Conjunctivitis, Allergic (1)

Broader conditions

Conjunctival Diseases (1)  ·  Conjunctivitis (1)  ·  Eye Diseases (1)  ·  Hypersensitivity (1)  ·  Hypersensitivity, Immediate (1)  ·  Immune System Diseases (1)

Interventions

cenegermin (1)

Sponsors

Dompé Farmaceutici S.p.A (1)

Countries

Argentina (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Japan (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Poland (1)  ·  South Korea (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

NIH funding

2025 (1)